Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sagimet Biosciences Inc. (SGMT) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sagimet Biosciences Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1400118.
Total stock buying since 2023: $1,301,675.
Total stock sales since 2023: $960,983.
Total stock option exercises since 2023: $4,447.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 84,535 | $772,226 | 0 | $0 |
| 2024 | 12,100 | $63,730 | 56,958 | $178,165 | 0 | $0 |
| 2023 | 79,065 | $1,237,945 | 662 | $10,592 | 5,630 | $4,447 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 84,535 | $772,226 | 0 | $0 |
| 2024-07 | 0 | $0 | 56,958 | $178,165 | 0 | $0 |
| 2024-03 | 12,100 | $63,730 | 0 | $0 | 0 | $0 |
| 2023-12 | 1,600 | $6,559 | 0 | $0 | 0 | $0 |
| 2023-11 | 590 | $1,386 | 0 | $0 | 0 | $0 |
| 2023-09 | 0 | $0 | 0 | $0 | 5,630 | $4,447 |
| 2023-07 | 76,875 | $1,230,000 | 662 | $10,592 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-21 | Rozek Elizabeth (General Counsel and CCO) | Sale | 10,780 | 9.13 | 98,475 |
| 2025-07-21 | Martins Eduardo Bruno (Chief Medical Officer) | Sale | 8,277 | 9.13 | 75,610 |
| 2025-07-21 | Happel David (President & CEO) | Sale | 65,478 | 9.13 | 598,141 |
| 2024-07-23 | Kemble George (Executive Chairman) | Sale | 23,625 | 3.17 | 74,820 |
| 2024-07-19 | Rozek Elizabeth (General Counsel and CCO) | Sale | 10,914 | 3.10 | 33,833 |
| 2024-07-19 | Kemble George (Executive Chairman) | Sale | 14,062 | 3.10 | 43,606 |
| 2024-07-19 | Martins Eduardo Bruno (Chief Medical Officer) | Sale | 8,357 | 3.10 | 25,906 |
| 2024-03-26 | Happel David (President & CEO) | Buy | 12,100 | 5.27 | 63,730 |
| 2023-12-07 | Happel David (President & CEO) | Buy | 1,600 | 4.10 | 6,559 |
| 2023-11-16 | Happel David (President & CEO) | Buy | 590 | 2.35 | 1,386 |
| 2023-09-07 | Kemble George (Executive Chairman) | Option Ex | 5,630 | .79 | 4,447 |
| 2023-07-18 | Nea 13 Gp, Ltd (10% Owner) | Buy | 30,000 | 16.00 | 480,000 |
| 2023-07-18 | Nea 13 Gp, Ltd (10% Owner) | Sale | 662 | 16.00 | 10,592 |
| 2023-07-18 | Seidenberg Beth C | Buy | 46,875 | 16.00 | 750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGMT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sagimet Biosciences Inc. (symbol SGMT, CIK number 1400118) see the Securities and Exchange Commission (SEC) website.